153 related articles for article (PubMed ID: 30048660)
1. Sirolimus for treatment of verrucous venous malformation: A retrospective cohort study.
Zhang G; Chen H; Zhen Z; Chen J; Zhang S; Qin Q; Liu X
J Am Acad Dermatol; 2019 Feb; 80(2):556-558. PubMed ID: 30048660
[No Abstract] [Full Text] [Related]
2. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
Vlahovic AM; Vlahovic NS; Haxhija EQ
Pediatrics; 2015 Aug; 136(2):e513-6. PubMed ID: 26148957
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
5. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
7. [Our experience with sirolimus for the treatment of complicated vascular anomalies].
Giménez-Aleixandre C; Méndez-Aguirre NA; Martínez-Menchón T; Girón Vallejo Ó; Fernández-Ibieta M; Ferri-Ñíguez B; Villamil V; Sánchez-Sánchez Á; Montoya-Rangel CA; Hernández-Bermejo JP
Cir Pediatr; 2019 Jan; 32(1):28-33. PubMed ID: 30714698
[TBL] [Abstract][Full Text] [Related]
8. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
9. Use of Multiple Sclerosant Agents in Vascular Malformation Management: A World in Endovascular Confusion and Chaos.
Yakes WF
J Vasc Interv Radiol; 2015 Oct; 26(10):1494-6. PubMed ID: 26408215
[No Abstract] [Full Text] [Related]
10. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations.
Geeurickx M; Labarque V
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1321-1333. PubMed ID: 33737259
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
12. Successful Treatment of a Complex Vascular Malformation With Sirolimus and Surgical Resection.
Goldenberg DC; Carvas M; Adams D; Giannotti M; Gemperli R
J Pediatr Hematol Oncol; 2017 May; 39(4):e191-e195. PubMed ID: 27820120
[TBL] [Abstract][Full Text] [Related]
13. Effects of sirolimus in the treatment of unresectable infantile hemangioma and vascular malformations in children: A single-center experience.
Cho YJ; Kwon H; Kwon YJ; Kim SC; Kim DY; Namgoong JM
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1488-1494. PubMed ID: 33836285
[TBL] [Abstract][Full Text] [Related]
14. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
15. Comment on "Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study": Are we missing the lymphatic malformation component?
Cai R; Yang X; Gu H; Chen H; Lin X
J Am Acad Dermatol; 2023 Mar; 88(3):e133-e134. PubMed ID: 30240774
[No Abstract] [Full Text] [Related]
16. Reply to "Comment on 'Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study': Are we missing the lymphatic malformation component?".
Chen H; Zhang G
J Am Acad Dermatol; 2023 Mar; 88(3):e135-e136. PubMed ID: 30240777
[No Abstract] [Full Text] [Related]
17. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
Sandbank S; Molho-Pessach V; Farkas A; Barzilai A; Greenberger S
Acta Derm Venereol; 2019 Oct; 99(11):990-996. PubMed ID: 31304557
[TBL] [Abstract][Full Text] [Related]
18. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
19. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
20. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
Kim D; Benjamin L; Wysong A; Hovsepian D; Teng J
Dermatol Ther; 2015; 28(4):218-21. PubMed ID: 25753853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
